Dysfunction of histone-modifying enzymes affects chromatin regulation and is involved in carcinogenesis, tumour progression and other diseases. Histone methyltransferases are a family of key histone-modifying enzymes, but their structures, functions and mechanisms are incompletely understood, thus constraining drug-design efforts. Here, preliminary steps towards structurefunction studies of Schizosaccharomyces pombe Set7, a putative histone methyltransferase and the first yeast full-length SET-domain-containing protein to be studied using X-ray crystallography, are reported. The methods from cloning to X-ray diffraction and phasing are discussed and the results will aid in prospective studies of histone-modifying enzymes.
Introduction
The intricate dynamics of euchromatin and heterochromatin maintenance regulate gene transcription. Large families of enzymes that modify, read and erase epigenetic marks on both DNA and histones are orchestrated in a molecular ballet, the mechanisms of which are not yet clearly understood. Histones are modified through phosphorylation, methylation, acetylation, ubiquitylation, citrullination and SUMOylation, amongst others. Subsequently, epigenetic readers recognize these specific marks, which may lead to the recruitment of various components of the transcription complex to either initiate or repress transcriptional programs. The tightly regulated interplay surrounding histone marks and chromatin states can be considered to be a 'histone code' that has yet to be deciphered (Zhang et al., 2012; Strahl & Allis, 2000) . Abnormality in the regulation of either DNA-modifying or histone-modifying enzymes is associated with an increasing number of pathologies, especially carcinogenesis and tumour progression (Cohen et al., 2011; Varier & Timmers, 2011) . Therefore, a better understanding of chromatin maintenance, remodelling and regulation by epigenetic modifying enzymes is of paramount importance.
Histone methylation on lysine and arginine residues mediated by the catalytic SET [Su(var)3-9, enhancer of zeste, trithorax] domain of histone methyltransferase (HMTase) is a key modification in chromatin maintenance. The SET domain of HMTase transfers one, two or three methyl groups from the coenzyme S-adenosylmethionine onto lysine or arginine residues, which can have both repressive and activating effects on transcription. The SET domain is conserved across species. Genomic and proteomic studies have identified at least 77 SET-domain-containing proteins in the human proteome, whereas in the fission yeast Schizosaccharomyces pombe 13 SET-containing proteins have been identified (Set1-Set3, Clr4 and Set5-Set13), which are encoded by the following genes: set1 + (SPCC306.04c), set2 + (SPAC29B12.02c), set3 (Wu et al., 2010; Herz et al., 2013) .
Amongst the 13 S. pombe SET enzymes, Set1, Set2, Clr4, Set9, Set10, Set11 and Set13 have been reported to possess methyltransferase activity (Noma & Grewal, 2002; Morris et al., 2005; Sadaie et al., 2008; Shirai et al., 2010) .
Set1, the homologue of the mammalian MLL H3K4 methyltransferase, is a component of the COMPASS complex that is responsible for the monomethylation, dimethylation and trimethylation of H3K4 (Noma & Grewal, 2002) . Set1 is involved in the ATM kinase Rad3-dependent pathway and is responsible for telomere maintenance and DNA repair (Kanoh et al., 2003) . Set2 methylates H3K36 and is involved in transcriptional elongation (Morris et al., 2005) . Clr4, the homologue of the mammalian Suv39h1 H3K9 methyltransferase, is the sole H3K9 methyltransferase in S. pombe (Nakayama et al., 2001) . Set9 is the sole H4K20 methyltransferase responsible for the recruitment of the checkpoint protein Crb2 during DNA-damage responses (Sanders et al., 2004) . Set11 methylates ribosomal protein L12 (Rpl12) during ribosomal assembly (Sadaie et al., 2008) and Set13 has been found to monomethylate Rpl42/43, which is associated with cell proliferation and ribosomal function (Shirai et al., 2010) .
Structural studies of histone-modifying enzymes are lagging behind other molecular and cellular biology studies. Of the 77 SET-containing enzymes identified in Homo sapiens, 34 lysineHMTase structures, including only four full-length lysineHMTases (SMYD2, SMYD3, SETD6 and SETD7), have been solved. In addition, out of 13 arginine-HMTase structures, ten full-length arginine-HMTases (PRMT5, PCMT1, FBL, METTL21A, METTL21B, METTL21C, METTL21D, CAMKMT, PRMT1, PRMT6 and CARM1) have been solved. Only two partial Saccharomyces cerevisiae HMTase structures have been solved: the N-terminal RRM domain of Set1 (PDB entry 2j8a; L. Tresaugues et al., unpublished work) and the Set2 SRI domain (PDB entry 2c5z; Vojnic et al., 2006) . Little is known about the structural details of the S. pombe SETcontaining proteins except for the crystal structure of the Clr4 catalytic SET domain (Min et al., 2002) .
In this study, in order to better understand histone methylation, we focused on the full-length S. pombe Set7, which contains a predicted structurally conserved SET domain. Little is known about Set7, especially its structure, enzymatic activity, substrate specificity and the characterization of Set7 mutants. Here, we crystallized Set7 from S. pombe with the aim of obtaining the first crystal structure of a full-length yeast SET-domain-containing methyltransferase and thus contributing to a better understanding of the structure-function relationship of HMTs.
Materials and methods
2.1. Macromolecule production 2.1.1. Cloning. Full-length set7 + (SPCC297.04c, 444 bp, 147 amino acids) was amplified using an S. pombe meiotic cDNA library ( Table 1 ). The set7 + PCR product flanked with SpeI and XhoI was inserted into the MCS of the protein-expression intein-tag vector pTYB12-HA, which was modified by inserting an HA tag (TMYPYDVPDYAA) at the XhoI and SmaI sites in the MCS of pTYB12 (New England Biolabs, Hitchin, England). The resultant pTYB12-set7 + -HA plasmid produces the intein-Set7 fusion protein with an HA tag at its C-terminus and several extra amino acids from the remaining restriction sites (Table 1 ). The construct was verified by sequencing (Solgent, Daejeon, Republic of Korea).
2.1.2. Protein expression and purification. Escherichia coli BL21 (DE3) cells transformed with the pTYB12-set7 + -HA plasmid were cultured in LB medium containing 100 mg l À1 ampicillin and Set7 protein expression was induced with 125 mM isopropyl -d-1-thiogalactopyranoside for 16 h at 12 C. Cells were harvested and lysed for 60 min in buffer A (20 mM Tris pH 8.5, 500 mM NaCl, 0.1 mM EDTA) containing 0.1% Triton X-100 and 1 mM phenylmethanesulfonyl fluoride followed by 20 cycles of sonication (2.5 min at amplitude 80) on ice. Cell debris was removed by centrifugation for 30 min at 12 000g at 4 C. The lysate was transferred to a new bottle and spun down for 30 min at 12 000g at 4 C and filtered using Corning 250 ml vacuum filters (Corning, New York, USA). The lysate containing CBD (chitin-binding domain)-inteinSet7 fusion protein was loaded onto a 50 ml column containing 15 ml chitin beads (New England Biolabs). To remove impurities, the column was washed with 100 bed volumes of buffer A containing 0.1% Triton X-100 followed by 20 bed volumes of buffer A without Triton X-100. The bacterial chaperone was removed by washing with seven bed volumes of buffer A containing 10 mM ATP and 2.5 mM MgCl 2 followed by washing with 20 bed volumes of buffer A. Cleavage of the intein tag was induced by incubation in buffer A with 50 mM -mercaptoethanol at 4 C for 64 h. S. pombe Set7 protein (19.57 kDa) was eluted in 65 ml buffer A, concentrated and washed with buffer A using 10K Amicon Ultra centrifugal filters (EMD Millipore, Billerica, Massachusetts, USA).
A secondary gel-filtration purification step was performed using an Ä KTAprime plus chromatography system with a Superdex 75 10/300 column (GE Healthcare, Little Chalfont, England) in buffer A with a flow rate of 0.4 ml min
À1
. Owing to pressure limitation on the Ä KTAprime plus using the Superdex 75 10/300 column, the flow rate is below the minimum recommended flow rate of 0.5 ml min
, which might explain the broad elution-peak profile (Fig. 1 ). Fractions were pooled and the buffer was switched to 10 mM Tris pH 7.5 using 10K Amicon Ultra centrifugal filters. The protein was concentrated to 6 mg ml À1 and confirmed by 15% SDS-PAGE stained with Coomassie Blue G-250 and Western blotting using HRP-conjugated -HA antibody (A190-108P, Bethyl Laboratories, Montgomery, Texas, USA). SDS-PAGE and native PAGE tend to indicate homogenous S. pombe Set7 during the crystallization phases (Fig. 2b) .
Crystallization
S. pombe Set7 protein (19.57 kDa) was crystallized using the hanging-drop method in 24-well plates (Hampton Research, Aliso Viejo, California, USA). Drops were set up using 1 ml of 6 mg ml À1 Set7 protein in 10 mM Tris buffer pH 7.5 with 1 ml of reservoir buffer followed by the addition of 0.4 ml of 0.1 M urea as an additive (Additive Screen, Hampton Research). Cover slides were sealed with type B mineral oil (Cargille Laboratories, Cedar Grove, New Jersey, USA) and incubated at 13 C. Crystals developed in two separate conditions: 0.2 M sodium phosphate dibasic, 20%(w/v) PEG 3350 pH 8.0 and 0.2 M magnesium formate dihydrate, 20%(w/v) PEG 3350 pH 7. In both conditions, Set7 quasi-crystals formed within 3 d that developed into solid crystals within 50 d (Fig. 2a) . Crystals were resolved on SDS-PAGE to ensure the quality and the molecular weight of 19.57 kDa. The crystals were dyed with Izit dye (Hampton Research) to distinguish macromolecular crystals from those of inorganic or small molecules. Birefringence of the macromolecular crystals was assessed under polarized light using a Nikon SMZ18 microscope. Crystallization information is summarized in Table 2 . S. pombe Set7 could also be crystallized using condition B but gave crystals of lower quality. Since no ice ring was observed in condition B without cryoprotectant and condition A yielded the best diffracting crystals, these were briefly washed in condition B. Eventually, a single data set (180 images at 1 oscillation) was collected at a wavelength of 0.97930 Å . The crystal size used in this study was $75 Â 25 Â 50 mm. 2.3.2. Data reduction and phasing. The crystal degraded quickly on the beamline after 66 images (1 oscillation); thus, the first 66 images of 180 were selected for further data reduction. The data were reduced using HKL-2000 to 2.45 Å resolution in space groups P6 5 22 and P6 1 22. There are two molecules in the asymmetric unit, and molecular replacement using the crystal structure of the Plasmodium falciparum putative histone methyltransferase PFL0690c (PDB entry 4rz0; Structural Genomics Consortium, unpublished work) with a sequence identity of 36% was used to phase the data.
Chain A of PDB entry 4rz0 was used as a search object for two S. pombe Set7 molecules in the asymmetric unit. The best molecular-replacement solution was found with a translationfunction Z-score (TFZ) of 5.2. Coot, REFMAC5 and BUSTER were used to build and refine the structure (Emsley et al., 2010;  research communications 
Results and discussion
Crystal structures of HMTases are needed to better comprehend chromatin dynamics and diseases caused by dysfunction of chromatin remodellers. Therefore, the rationale of this study was to shed light on full-length structures of HMTs to contribute to elucidating chromatin maintenance and regulation along with associated diseases. In this study, we cloned, expressed and crystallized an S. pombe putative HMTase, Set7 which is the first full-length yeast HMTase structure to be solved. An S. pombe meiotic cDNA library was used to clone set7 + into a modified pTYB12-HA plasmid fused with an intein tag at the N-terminus and an HA tag at the C-terminus of set7 + . Noteworthy, out of 13 S. pombe SET-containing genes, only set6 + and set7 + contain introns. The HA tag (TMYPYDVP-DYAA) was added to increase the stability and solubility of the recombinant protein, while allowing protein identification by immunoblot. Approximately 15 g of cells from a 9 l LB protein-expression batch were lysed and Set7 protein was purified using the intein-tag affinity column, yielding 1.1 mg of purified protein. The protein was further purified by gel filtration using a Superdex 75 10/300 column (Fig. 1) .
For crystallization of Set7, the protein concentration was increased to 12 mg ml À1 in 10 mM Tris buffer pH 7.5. Initial hits showing quasi-crystals or small crystals were reproduced at a lower concentration of 6 mg ml
À1
. Solid useful crystals appeared within 50 d of incubation at 13 C and transitions through multiple states are shown in Fig. 2 . Microcrystals appeared within 72 h, which next developed into quasi-crystals by day 7 and part of the drop further evolved into a phaseseparation state. Solid crystals appeared within 21 d following the disappearance of the phase-separation state (Fig. 2a) . The dynamic process of protein phase change was investigated by SDS-PAGE and native PAGE, which may suggest that S. pombe Set7 remains in a homogenous state during the crystallization phase (Fig. 2b) . However, some degradation of S. pombe Set7 was observed (Fig. 2b) .
To investigate the authenticity of the crystals, two additional control experiments were performed. The blue Izit dye was readily absorbed in protein crystal solvent channels, resulting in dark blue crystals, clearly supporting that the crystals were macromolecular and not of inorganic salts. Secondly, crystals were examined under polarized light and clearly showed birefringence ( Supplementary Fig. S1 ).
The crystals were found to be delicate and difficult to handle. Manual harvesting of the crystals at the synchrotron was found to be the best way to minimize stress and ice-ring formation and to maximize diffraction quality. The best diffraction, to 2.45 Å resolution, was observed with crystals incubated in 0.2 M sodium phosphate dibasic, 20%(w/v) PEG 3350 pH 8.0 with no additional cryoprotectant (Supplementary Fig. S2 ). As the space group was uncertain, 180 diffraction images at 1 oscillation were collected with a 5 s exposure time. However, the crystal quality deteriorated during data collection owing to radiation damage (data not shown). Data reduction was performed using the first 66 images, and the crystal unit-cell parameters were identified as a = b = 66.8, c = 255.9 Å . The space group is ambiguous, being either P6 1 22 or its enantiomorph P6 5 22, both with = = 90, = 120
. Cellcontent analysis indicated the likelihood of two monomers per asymmetric unit, with a solvent content of 49.35% and a V M of 2.43 Å 3 Da À1 (Table 3) . Only a native data set could be collected; therefore, molecular replacement was used to phase the data. An NCBI BLAST search against the Protein Data Bank for the S. pombe Set7 sequence returned the crystal structure of P. falciparum putative histone methyltransferase PFL0690c (PDB entry 4rz0) with 36% sequence identity as a possible candidate for molecular replacement. As the space group is ambiguous, using Phaser for molecular replacement we explored the enantiomorphic P6 1 22 and P6 5 22 space groups with PDB entry 4rz0 as a monomeric search model. A potential solution was found in space group P6 5 22 with two molecules in the asymmetric unit. Initial electron-density map inspection showed unambiguous and continuous density around the search model. After several rounds of model rebuilding with Coot and refinement with both REFMAC5 and BUSTER, the electron-density maps became convincing, with clear continuous et al., 2012; Fig. 3 ). The identity of these two proteins is relatively low: the search model PDB entry 4rz0 is weakly related to S. pombe Set7, with only 36% sequence identity. Therefore, owing to backbone-tracing errors, the R factor and R free are currently at 43.8 and 45.4%, respectively. It is noteworthy that 96 residues out of 334 (28.7%) are still missing at this early stage of model building and refinement. Specifically, the missing amino acids are as follows. In chain A, amino acids À6 to 0, residues added owing to cloning at the N-terminus; amino acids 58-74, residues predicted to be a conserved -helix; amino acids 106-115, residues predicted to be a flexible loop; and amino acids 147-163, an HA tag added at the C-terminus for increased protein stability. In chain B, amino acids À6 to 0, residues added owing to cloning at the N-terminus; amino acids 58-71, residues predicted to be a conserved -helix; amino acids 106-115, residues predicted to be a flexible loop; and amino acids 147-163, an HA tag at the C-terminus. Protein-backbone as well as side-chain placement is clearly visible with convincing electron-density maps (Fig. 3) . The initial analysis of the structure does not support a biological dimer in the crystal, consistent with gel electrophoresis of the purified soluble protein. In order to ensure the validity of the molecular-replacement solution and subsequent modelbuilding steps, 2F o À F c and F o À F c electron-density OMIT maps were calculated (Fig. 3b) . Residues between Ile6 and Thr15 were omitted and both the 2F o À F c OMIT map contoured at 1 and the F o À F c OMIT positive electron density contoured at 3 support a valid phasing solution. Taken together, the details of the crystallization process and the phasing of S. pombe Set7 will contribute to the structural biology studies of HMTases in eukaryotes.
